Collegium Pharmaceutical (COLL) Change in Intangibles (2018 - 2020)
Collegium Pharmaceutical (COLL) recorded quarterly Change in Intangibles of $1.4 million in Q2 2020, down 99.61% quarter-over-quarter from $366.8 million in Q1 2020.
Collegium Pharmaceutical (COLL) Change in Intangibles (2018 - 2020) Analysis & Trends
Collegium Pharmaceutical's Change in Intangibles history runs 2 years deep, the most recent figure standing at $1.4 million for Q2 2020.
- In Q2 2020, Change in Intangibles changed N/A year-over-year to $1.4 million; the TTM figure through Dec 2020 stood at $368.2 million (changed N/A YoY), while the FY2020 annual figure was $368.2 million, changed N/A from the prior year.
- Change in Intangibles was $1.4 million for Q2 2020 at Collegium Pharmaceutical, down from $366.8 million in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $366.8 million in Q1 2020 to a low of $116000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Collegium Pharmaceutical | 1.11 Bn | 818.84 Mn | 117.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 1.42 Mn |
| Jun 30, 2020 | 1.42 Mn |
| Mar 31, 2020 | 366.81 Mn |
| Mar 31, 2020 | 366.81 Mn |
| Jun 30, 2018 | 116,000.00 |
| Jun 30, 2018 | 116,000.00 |
| Mar 31, 2018 | 18.76 Mn |
| Mar 31, 2018 | 18.76 Mn |